HK1022644A1 - Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation. - Google Patents

Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation.

Info

Publication number
HK1022644A1
HK1022644A1 HK00101714A HK00101714A HK1022644A1 HK 1022644 A1 HK1022644 A1 HK 1022644A1 HK 00101714 A HK00101714 A HK 00101714A HK 00101714 A HK00101714 A HK 00101714A HK 1022644 A1 HK1022644 A1 HK 1022644A1
Authority
HK
Hong Kong
Prior art keywords
formulation
antiviral
antifungal
radiation absorbing
derivatives
Prior art date
Application number
HK00101714A
Other languages
English (en)
Inventor
Benny Johansson
Bo Niklasson
Original Assignee
Noviscens Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noviscens Ab filed Critical Noviscens Ab
Publication of HK1022644A1 publication Critical patent/HK1022644A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HK00101714A 1996-12-16 2000-03-21 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation. HK1022644A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604610A SE9604610D0 (sv) 1996-12-16 1996-12-16 Medical composition
PCT/SE1997/002126 WO1998026788A1 (en) 1996-12-16 1997-12-16 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation

Publications (1)

Publication Number Publication Date
HK1022644A1 true HK1022644A1 (en) 2000-08-18

Family

ID=20404983

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101714A HK1022644A1 (en) 1996-12-16 2000-03-21 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation.

Country Status (19)

Country Link
US (1) US6562802B2 (ko)
EP (1) EP0957927B1 (ko)
JP (1) JP4703792B2 (ko)
KR (1) KR20000069521A (ko)
CN (1) CN1245431A (ko)
AT (1) ATE288760T1 (ko)
AU (1) AU720008B2 (ko)
CA (1) CA2275321C (ko)
CZ (1) CZ295459B6 (ko)
DE (1) DE69732495T2 (ko)
ES (1) ES2236837T3 (ko)
HK (1) HK1022644A1 (ko)
HU (1) HUP0000557A3 (ko)
NO (1) NO321048B1 (ko)
NZ (1) NZ336313A (ko)
PL (1) PL191316B1 (ko)
RO (1) RO120122B1 (ko)
SE (1) SE9604610D0 (ko)
WO (1) WO1998026788A1 (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356840A1 (en) * 1998-12-24 2000-07-06 Four Star Partners Compositions and methods of using the same
WO2001043717A1 (en) * 1999-12-17 2001-06-21 The Procter & Gamble Company Compositions for efficient release of active ingredients
JP2003524635A (ja) * 1999-12-23 2003-08-19 アイヴリア インコーポレイテッド 活性作用物の局所デリバリー用キトサンバイオポリマー
JP4771502B2 (ja) * 2000-06-13 2011-09-14 住化エンビロサイエンス株式会社 抗アレルゲン組成物及びアレルゲン不活化方法
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
JP2004508316A (ja) * 2000-09-11 2004-03-18 ジヨンソン・アンド・ジヨンソン・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 化粧品及び薬用組成物及びその使用
US20040052826A1 (en) * 2000-09-11 2004-03-18 Elena Fernandez-Kleinlein Cosmetic and pharmaceutical compositions and their use
GB0024489D0 (en) * 2000-10-06 2000-11-22 Reckitt Benckiser Uk Ltd Improvements in or relating to organic compositions
EP1609468A3 (en) * 2000-11-22 2006-01-25 Rxkinetix, Inc. A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
KR100423666B1 (ko) * 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
US7998699B2 (en) 2002-08-15 2011-08-16 University Of South Florida Early detection of pathogens in blood
CN100453121C (zh) * 2002-11-12 2009-01-21 吴奕光 一种医用敷料及其生产方法
EP1438954A1 (de) * 2003-01-18 2004-07-21 Beiersdorf AG Erhöhung der Thermostabilität und Verbesserung der Fliesseigenschaften von chitosanhaltigen Formulierungen
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
PT1654387E (pt) * 2003-08-15 2009-07-20 Univ South Florida Materiais e métodos para a captura de patogénios e a remoção de ácido aurintricarboxílico de uma amostra
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
US20100239655A1 (en) * 2004-12-09 2010-09-23 Georgia Levis Taurine-based compositions and therapeutic methods
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
US7691830B2 (en) * 2005-02-17 2010-04-06 Clive Elson Method and composition for treatment of a mucosal tissue disorder
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
US20100160254A1 (en) * 2006-04-04 2010-06-24 Marinomed Biotechnologie Gmbh Cellulose Sulfate for the Treatment of Rhinovirus Infection
US20090311348A1 (en) * 2006-05-05 2009-12-17 Sigurbjorn Einarsson Pharmeceutical and cosmetic use of silica
US7964002B2 (en) 2006-06-14 2011-06-21 Chemtura Corporation Antioxidant additive for biodiesel fuels
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
EP1958639A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans for the treatment of nail inflammatory diseases
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
WO2008124055A1 (en) 2007-04-04 2008-10-16 The Board Of Trustees Of The University Of Arkansas Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions
US8131278B2 (en) * 2008-12-05 2012-03-06 Nokia Corporation Method, apparatus, and computer program product for application-based communications
WO2010108098A1 (en) * 2009-03-19 2010-09-23 Oregon Biomedical Engineering Institute, Inc. Countermeasure methods and devices
WO2010109421A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
US20120040927A1 (en) * 2009-04-20 2012-02-16 Apex Laboratories Private Limited Medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it.
WO2010122453A1 (en) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
EP2482807A4 (en) 2009-10-02 2013-04-24 Brigham & Womens Hospital COMPOSITIONS AND METHODS FOR PROPHYLAXIS FOR CONTACT ECZEMA
US20110225809A1 (en) * 2010-03-17 2011-09-22 Alan Francis Daher Apparatus for removably attaching an item to a surface
CN103479400A (zh) * 2012-06-11 2014-01-01 浙江我武生物科技股份有限公司 一种含有漆酚的皮炎诊断贴剂及其制备方法
FR2993466B1 (fr) * 2012-07-18 2014-08-15 Prevor Internat Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau
WO2014041489A2 (en) * 2012-09-11 2014-03-20 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
CN103951763B (zh) * 2014-04-22 2016-06-22 大连民族学院 O-烷基氨基甲酸酯壳聚糖、转基因复合物微粒及其制备方法
JP6742312B2 (ja) * 2014-08-05 2020-08-19 アマンタン・エクスペール 皮膚保護組成物
KR102533463B1 (ko) 2015-02-26 2023-05-16 스퀘어렉스 파마슈티컬 코포레이션 단순 포진 바이러스 감염을 치료하기 위한 비특이적 지연형 과민성 반응
ES2760520T3 (es) * 2015-07-31 2020-05-14 Univ Warszawski Medyczny Composición de emulsión antipsoriásica que se compone de cefazolina
JP2018184362A (ja) * 2017-04-25 2018-11-22 株式会社Ｒ−ｇｏｏｄ 殺菌性組成物
CN107973866B (zh) * 2017-12-15 2020-08-28 武汉工程大学 具有高的sod酶活性的四氮大环锰配合物修饰壳聚糖复合材料及其制备方法
CN108892743A (zh) * 2018-05-28 2018-11-27 南京工业大学 用于光动力抗菌的纳米光敏剂，其制备方法及应用
CN115177738A (zh) * 2022-05-07 2022-10-14 中国人民解放军陆军军医大学第一附属医院 一种促进核素排泄的乙二醇壳聚糖dtpa及其制备方法
WO2024013711A1 (en) 2022-07-15 2024-01-18 Universidade De Coimbra Topical composition and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1027501B (it) * 1968-12-06 1978-12-20 Muzzarelli Weckx M G F Chitina chitosano e derivati usati come supporti cromatografici e come adsorbenti per la raccolta di ioni dalle soluzuoni acquose e organiche dall acqua potabile e marina
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
US4031025A (en) * 1971-05-10 1977-06-21 Societe Anonyme Dite: L'oreal Chitosan derivative, sequestering agents for heavy metals
US4382864A (en) * 1980-08-08 1983-05-10 Kurita Water Industries Ltd. Process for dewatering sludges
DE3245784A1 (de) * 1982-12-10 1984-06-14 Wella Ag, 6100 Darmstadt Kosmetisches mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere chitosanderivate sowie verfahren zu ihrer herstellung
US5000945A (en) * 1986-04-22 1991-03-19 Ajinomoto Co., Inc. Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US4929722A (en) * 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
JPH0696489B2 (ja) * 1987-05-11 1994-11-30 株式会社資生堂 皮膚および毛髪用組成物
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
US5140043A (en) * 1989-04-17 1992-08-18 Duke University Stable ascorbic acid compositions
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
WO1992009636A1 (en) * 1990-11-30 1992-06-11 Baker Cummins Dermatologicals, Inc. Skin protective compositions and method of inhibiting skin irritation
US5348799A (en) * 1991-09-03 1994-09-20 Minnesota Mining And Manufacturing Company Antistatic coatings comprising chitosan acid salt and metal oxide particles
JPH07196468A (ja) * 1993-12-30 1995-08-01 Sansho Seiyaku Co Ltd 化粧料
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
SE9403138L (sv) 1994-09-20 1996-03-21 Asea Brown Boveri Manöverdon för brytare
US5698476A (en) * 1995-03-01 1997-12-16 The Clorox Company Laundry article for preventing dye carry-over and indicator therefor
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
US5646221A (en) * 1995-03-31 1997-07-08 Kowa Co., Ltd. Adhesive base material
TW427912B (en) * 1996-12-20 2001-04-01 Kao Corp Detergent composition
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations

Also Published As

Publication number Publication date
PL191316B1 (pl) 2006-04-28
ATE288760T1 (de) 2005-02-15
CZ295459B6 (cs) 2005-08-17
CN1245431A (zh) 2000-02-23
PL333915A1 (en) 2000-01-31
DE69732495T2 (de) 2006-01-05
EP0957927B1 (en) 2005-02-09
EP0957927A1 (en) 1999-11-24
NO321048B1 (no) 2006-03-06
ES2236837T3 (es) 2005-07-16
AU5502798A (en) 1998-07-15
KR20000069521A (ko) 2000-11-25
JP2001506649A (ja) 2001-05-22
JP4703792B2 (ja) 2011-06-15
CA2275321A1 (en) 1998-06-25
US20020128310A1 (en) 2002-09-12
RO120122B1 (ro) 2005-09-30
US6562802B2 (en) 2003-05-13
SE9604610D0 (sv) 1996-12-16
CZ213599A3 (cs) 1999-11-17
HUP0000557A2 (hu) 2000-06-28
NO992841D0 (no) 1999-06-11
NO992841L (no) 1999-08-16
NZ336313A (en) 2000-01-28
AU720008B2 (en) 2000-05-18
HUP0000557A3 (en) 2001-11-28
WO1998026788A1 (en) 1998-06-25
CA2275321C (en) 2009-02-03
DE69732495D1 (de) 2005-03-17

Similar Documents

Publication Publication Date Title
HK1022644A1 (en) Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation.
AU3663295A (en) Curable coating compositions containing carbamate additives
NZ243335A (en) Preserved topical sunscreens.
CA2134239A1 (en) Pretargeting methods and compounds
CA2142576A1 (en) Antiperspirant Deodorant Compositions
ES2157268T3 (es) Composiciones cosmeticas y dermatologicas que contienen acidos fenilen-1,4-bisbenzimidazolsulfonicos.
CA2168249A1 (en) Psoriasis treatment
EP0158412A3 (en) Sunscreen compositions
IN161414B (ko)
CA2212256A1 (en) Indanylidene compounds, a process for their preparation and their use as uv absorbers
CA2061679A1 (en) Cationic compositions for skin
CA2204888A1 (en) Absorbent material
BR9907314A (pt) Utilização de um éster de celulose
AU5182093A (en) Photochromic compounds
CA2153543A1 (fr) Composition cosmetique et/ou dermatologique gelifiee, riche en solvant et contenant des particules creuses, ses applications
AU2653995A (en) Detergent compositions with oleoyl sarcosinate and polymeric dispersing agent
CA2233331A1 (en) Use of sphingosylphosphorylcholine as a wound-healing agent
WO2001046178A3 (en) Substituierte bisindolymaleimide
ATE301688T1 (de) Vernetzbare polyethylenzusammensetzung
WO1999024042A3 (en) Stable antiandrogenic gel composition
EP0248366A3 (en) Smoothing agent for groutings
Gordienko et al. Radiation Modification of Polyethylene Containing Aerosil With Functional Groups
CA2267489A1 (en) Tree resistant cable
MX173729B (es) Composiciones curables de revestimiento que inc luyen catalizadores de sulfonimida
CA2301649A1 (en) Burn treatment composition

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20171215